Nutritional interventions for reducing gastrointestinal toxicity in adults undergoing radical pelvic radiotherapy

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 11, 2013, Pages

  Henson, Caroline C ^a   Burden, Sorrel ^b   Davidson, Susan E ^c   Lal, Simon ^d  

^a ROYAL BOLTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; COUNSELING; DIARRHEA; DIETARY SUPPLEMENT; GASTROINTESTINAL TOXICITY; HOSPITALIZATION; HUMAN; LIFESTYLE MODIFICATION; LIPID DIET; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PELVIS CANCER; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT DURATION; DIET; ELEMENTAL DIET; GASTROINTESTINAL TRACT; METHODOLOGY; PELVIS; RADIATION EXPOSURE; RADIATION INJURY; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; DIARRHEA; DIET; FOOD, FORMULATED; GASTROINTESTINAL TRACT; HUMANS; PELVIS; RADIATION INJURIES; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84900971904     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009896.pub2     Document Type: Review

References (53)

1. Brown MS, Buchanan RB, Karran SJ. Clinical observations on the effects of elemental diet supplementation during irradiation. Clinical Radiology 1980;31:19-20.
2. Bye A, Kaasa S, Ose T, Sundfor K, Trope C. The influence of low fat, low lactose diet on diarrhoea during pelvic radiotherapy. Clinical Nutrition 1992;11:147-53.
3. Capirci C, Polico C, Mondoliti G, Zorat PL, Gava A, Turcato G, et al. Prevention of acute small bowel toxicity in pelvic radiotherapy by a specific computerised diet therapy. Results of a multicentre randomised trial 1993:S94.
4. Capirci C, Polico C, Amichetti M, Bonetta A, Gava A, Marenzano E, et al. Diet prevention of radiation acute enteric toxicity: multicentric randomised study. Radiotherapy and Oncology 2000;56(Suppl 1):S44.
5. Craighead PS, Young S. Phase II study assessing the feasibility of using elemental supplements to reduce acute enteritis in patients receiving radical pelvic radiotherapy. American Journal of Clinical Oncology 1998;21(6):573-8.
6. McGough C, Wedlake L, Baldwin C, Hackett C, Norman AR, Blake P, et al. Clinical trial: normal diet vs. partial replacement with oral E028 formula for the prevention of gastrointestinal toxicity in cancer patients undergoing pelvic radiotherapy. Alimentary Pharmacology & Therapeutics 2008;27(11):1132-9.
7. Murphy J, Stacey D, Crook J, Thompson B, Panetta D. Testing control of radiation-induced diarrhea with a psyllium bulking agent: a pilot study. Canadian Oncology Nursing Journal 2000;10(3):96-100.
8. Pettersson A, Johansson B, Persson C, Berglund A, Turesson I. Effects of a dietary intervention on acute gastrointestinal side effects and other aspects of health-related quality of life: a randomized controlled trial in prostate cancer patients undergoing radiotherapy. Radiotherapy & Oncology 2012;103(3):333-40.
9. Stryker JA, Bartholomew M. Failure of lactose-restricted diets to prevent radiation-induced diarrhea in patients undergoing whole pelvis irradiation. International Journal of Radiation Oncology, Biology, Physics 1986;12(5):789-92.
10. Wedlake LJ, McGough C, Shaw C, Klopper T, Thomas K, Lalji A, et al. Clinical trial: efficacy of a low or modified fat diet for the prevention of gastrointestinal toxicity in patients receiving radiotherapy treatment for pelvic malignancies. Journal of Human Nutrition and Dietetics 2012;25:247-59.
11. Ahmad IU, Forman JD, Sarkar FH, Hillman GG, Heath E, Vaishampayan U, et al. Soy isoflavones in conjunction with radiation therapy in patients with prostate cancer. Nutrition & Cancer 2010;62(7):996-1000.
12. Bartalone RL, Tyrpak D, Browne RW, Wilding GE, Horvath PJ, Brown JK. Nutritional status and intake post nutritional supplementation in prostate cancer patients undergoing radiotherapy. The FASEB Journal 2009;23:S1.
13. Bounous G, Le Bel E, Shuster J, Gold P, Tahan WT, Bastin E. Dietary protection during radiation therapy. Strahlentherapie 1975;149(5):476-83.
14. De Maria D, Falchi AM, Venturino P. Adjuvant radiotherapy of the pelvis with or without reduced glutathione: a randomized trial in patients operated on for endometrial cancer. Tumori 1992;78(6):374-6.
15. Foster KJ, Brown MS, Alberti KG, Buchanan RB, Dewar P, Karran SJ, et al. The metabolic effects of abdominal irradiation in man with and without dietary therapy with an elemental diet. Clinical Radiology 1980;31(1):13-7.
16. Kinsella TJ, Malcolm AW, Bothe A Jr, Valerio D, Blackburn GL. Prospective study of nutritional support during pelvic irradiation. International Journal of Radiation Oncology, Biology, Physics 1981;7(4):543-8.
17. Kozelsky TF, Meyers GE, Sloan JA, Shanahan TG, Dick SJ, Moore RL, et al. Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy. Journal of Clinical Oncology 2003;21(9):1669-74.
18. Lodge N, Evans ML, Wilkins M, Blake PR, Fryatt I. A randomized cross-over study of the efficacy of codeine phosphate versus Ispaghula husk in patients with gynaecological cancer experiencing diarrhoea during pelvic radiotherapy. European Journal of Cancer Care 1995;4(1):8-10.
19. Mateos Dominguez M, Olivera J, Vara J, Luna J, Iglesias T, Perez AM, et al. Glutamine treatment for preventing acute rectitis and cystitis in patients affected of prostate cancer treated with radiotherapy. Radiotherapy and Oncology 2010;96:S402.
20. McArdle AH, Reid EC, Laplante MP, Freeman CR. Prophylaxis against radiation injury. The use of elemental diet prior to and during radiotherapy for invasive bladder cancer and in early postoperative feeding following radical cystectomy and ileal conduit. Archives of Surgery 1986;121(8):879-85.
21. Membrive Conejo I, Reig Castillejo A, Rodriguez de Dios N, Foro Arnalot P, Sanz Latiesas J, Lozano Galan J, et al. Prevention of acute radiation enteritis: efficacy and tolerance of glutamine. Clinical & Translational Oncology 2011;13(10):760-3.
22. Mucke R, Glatzel M, Riesenbeck D, Bernd Skorka R, Seifert G, Buntzel J, et al. Sodium selenite in gynecologic radiation oncology - first results of a phase III study. Trace Elements & Electrolytes 2004;21(2):78-82.
23. Mucke R, Glatzel M, Reichl B, Bernd Skorka R, Buntzel J, Bruns F, et al. Sodium selenite in gynecologic radiation oncology: Results of a prospective randomized observation study. Trace Elements and Electrolytes 2006;23(3):173-7.
24. Muecke R, Schomburg L, Glatzel M, Berndt-Skorka R, Baaske D, Reichl B, et al. Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology. International Journal of Radiation Oncology Biology Physics 2010;78(3):828-35.
25. Ohshima T, Tsukiyama I, Mio A, Ito O, Sugawara M. Double blind test of L-cysteine for protection against radiation-induced side effects in man [author's translation from Japanese]. Nippon Igaku Hoshasen Gakkai Zasshi - NipponActa Radiologica 1977;37(5):444-62.
26. Rotovnik Kozjek N, Kompan L, Soeters P, Oblak I, Mlakar Mastnak D, Mozina B, et al. Oral glutamine supplementation during preoperative radiochemotherapy in patients with rectal cancer: a randomised double blinded, placebo controlled pilot study. Clinical Nutrition 2011;30(5):567-70.
27. Shah D, Brown JK, Browne RW, Horvath P, Tyrpak DA, Wilding GE. Response to antioxidant dietary supplements during radiotherapy for prostate cancer. American Journal of Clinical Oncology 2011;34(2):211-2.
28. Valerio D, Overett L, Malcolm A, Blackburn GL. Nutritional support for cancer patients receiving abdominal and pelvic radiotherapy: a randomized prospective clinical experiment of intravenous versus oral feeding. Surgical Forum 1978;29:145-8.
29. Andreyev J. Gastrointestinal complications of pelvic radiotherapy: are they of any importance?. Gut 2005;54(8):1051-4.
30. Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. The Lancet Oncology 2007;8(11):1007-17.
31. Bentzen SM. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology. Nature Reviews Cancer 2006;6(9):702-13.
32. Bourne RG. The relationship between early and late gastrointestinal complications of radiation therapy for carcinoma of the cervix. International Journal of Radiation Oncology Biology Physics 1983;9(10):1445-50.
33. Coles CE, Burgess L, Tan LT. An audit of delays before and during radical radiotherapy for cervical cancer-effect on tumour cure probability. Clinical Oncology 2003;15:47-54.
34. Dörr W. Pathogenesis of normal tissue side-effects. In: Joiner M, van der Kogel, A editor(s). Basic Clinical Radiobiology. 4th Edition. London: Hodder Arnold, 2009:183-90.
35. Fernández-Bañares F, Villá S, Esteve M, Roca M, Cabré E, Abad-Lacruz A, et al. Acute effects of abdominopelvic irradiation on the orocecal transit time: its relation to clinical symptoms, and bile salt and lactose malabsorption. American Journal of Gastroenterology 1991;86(12):1771-7.
36. Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiotherapy and Oncology 1992;25:273-9.
37. Gami B, Harrington K, Blake P, Dearnaley D, Tait D, Davies J, et al. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Alimentary Pharmacology & Therapeutics 2003;18(10):987-94.
38. Hauer-Jensen M, Wang J, Denham JW. Bowel injury: current and evolving management strategies. Seminars in Radiation Oncology 2003;13(3):357-71.
39. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
40. Jereczek-Fossa BA, Jassem J, Badzio A. Relationship between acute and late normal tissue injury after postoperative radiotherapy in endometrial cancer. International Journal of Radiation Oncology Biology Physics 2002;52(2):476-82.
41. Jereczek-Fossa BA, Zerini D, Fodor C, Santoro L, Serafini F, Cambria R, et al. Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy. International Journal of Radiation Oncology Biology Physics 2010;78(1):26-34.
42. Kirwan JM, Symonds P, Green JA. A systematic review of acute and late toxicity for cervical cancer. Radiotherapy and Oncology 2003;68:217-26.
43. McGough C, Baldwin C, Frost G, Andreyev HJN. Role of nutritional intervention in patients treated with radiotherapy for pelvic malignancy. British Journal of Cancer 2004;90(12):2278-87.
44. Peters WA 3rd, Liu PY, Barrett RJ 2nd, Stock RJ, Monk BJ, Berek JS, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. Journal of Clinical Oncology 2000;18(8):1606-13.
45. Royal College of Radiologists. The timely delivery of radical radiotherapy: standards and guidelines for the management of unscheduled treatment interruptions. 3rd Edition. London: Royal College of Radiologists, 2008.
46. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager. 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
47. Theis VS, Sripadam R, Ramani V, Lal S. Chronic radiation enteritis. Clinical Oncology 2010;22(1):70-83.
48. Wang C-J, Leung SW, Chen H-C, Sun L-M, Fang F-M, Huang E-Y, et al. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect. International Journal of Radiation Oncology Biology Physics 1998;40(1):85-91.
49. Wedlake L, Thomas K, McGough C, Andreyev HJN. Small bowel bacterial overgrowth and lactose intolerance during radical pelvic radiotherapy: an observational study. European Journal of Cancer 2008;44(15):2212-7.
50. Wedlake LJ, Thomas K, Lalji A, Blake P, Khoo V, Tait D, et al. Predicting late effects of pelvic radiotherapy: is there a better approach?. International Journal of Radiation Oncology Biology Physics 2010;78(4):1163-70.
51. Weiss E, Hirnle P, Arnold-Bofinger H, Hess CF, Bamberg M. Therapeutic outcome and relation of acute and late side effects in the adjuvant radiotherapy of endometrial carcinoma stage I and II. Radiotherapy and Oncology 1999;53(1):37-44.
52. West CML, Davidson SE. Measurement tools for gastrointestinal symptoms in radiation oncology. Current Opinion in Supportive & Palliative Care 2009;3(1):36-40.
53. Yeoh EK, Lui D, Lee NY. The mechanism of diarrhoea resulting from pelvic and abdominal radiotherapy; a prospective study using selenium-75 labelled conjugated bile acid and cobalt-58 labelled cyanocobalamin. British Journal of Radiology 1984;57(684):1131-6.